Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Squarer Ron
Squarer Ron (SEC CIK 0001454001) files insider reports with the SEC as Director of Nuvalent, Inc. (NUVL), Director of ADC Therapeutics SA (ADCT) and Director of Travere Therapeutics, Inc. (TVTX).
Signal8 holds 10 ownership filings by Squarer Ron (2 Form 3, 8 Form 4), filed between May 16, 2025 and Jul 15, 2026. Those filings report 9 transactions, the latest on Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Squarer Ron's filings is in CAMBRIDGE, MA.
Other insiders filing for Nuvalent, Inc. (NUVL)
- Flynn James E, Director
- Meyers Michael L., Director
- Balcom Alexandra, Chief Financial Officer
- Srivastava Sapna, Director
- Oliger Christy J., Director
- Turner Christopher Durant, Chief Medical Officer